Restricting our analysis to patients with CD34-positive AML, we also observed a trend for higher CIR in patients with high pre-HSCT BAALC/ABL1 copy numbers despite low patient numbers (P=.06, n=31, Supplementary Material). The gene discussed is BAALC; the disease is acute myeloid leukemia.